The Impact of Sarcopenic Obesity on the Course of Chronic Obstructive Pulmonary Disease in Elderly Men
https://doi.org/10.58838/2075-1230-2026-104-1-44-51
Abstract
The objective: to study the potential effect of sarcopenic obesity (SO) on the course of chronic obstructive pulmonary disease (COPD) in elderly men.
Subjects and Methods. Seventy-four men aged 60-74 years were examined. All of them had COPD GOLD II, Group A or B, and a post-bronchodilator FEV1/FVC ratio <0.7, COPD Assessment Test < 20 points. 36 patients had sarcopenic obesity.
Results. Patients with COPD+SO versus COPD Group were older (p=0.047), had more pronounced inflammaging according to the neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and systemic inflammatory index. When assessing relationship between MLR and percentage of body fat (PBF), a direct relationship was established (p=0.842, p<0.001). In COPD+SO Group, FEV1 values were lower (p=0.010), and the chance of moderate dyspnea (mMRS=2) was 9.7 times higher. The impact of COPD on the quality of life of patients (according to SAT test) was 8.4 times higher when combined with SO. Patients with mild dyspnea (0-1 as per) had significantly higher muscle mass values than those with moderate or severe dyspnea, regardless of their SO status (p=0.04). Patients with COPD+SO had more pronounced impairments of their physical activity according to the 6MW and 5.squat-stand tests (p<0.001).
About the Authors
L. V. Vasilyeva
Voronezh State Medical Academy Named after N.N. Burdenko, Russian Ministry of Health
Russian Federation
Russian Federation
Liudmila V. Vasilyeva, Doctor of Medical Sciences, Professor, Head of Department of Propaedeutics of Internal Diseases
10 Studencheskaya St., Voronezh, 394036;
Phone: +7 (473) 259-89-90
S. Yu. Popov
Aldomed Medical Center
Russian Federation
Russian Federation
Sergey Yu. Popov, Doctor
55 Karla Marksa St., Buturlinovka, Voronezh Region, 397500;
Phone: +7 (47361) 3-36-35
E. V. Gosteva
Voronezh State Medical Academy Named after N.N. Burdenko, Russian Ministry of Health
Russian Federation
Russian Federation
Elena V. Gosteva, Doctor of Medical Sciences, Associate Professor, Professor of Department of Propaedeutics of Internal Diseases
10 Studencheskaya St., Voronezh, 394036;
Phone: +7 (473) 259-89-90
E. Yu. Suslova
Voronezh State Medical Academy Named after N.N. Burdenko, Russian Ministry of Health
Russian Federation
Russian Federation
Ekaterina Yu. Suslova, Candidate of Medical Sciences, Associate Professor of Department of Propaedeutics of Internal Diseases
10 Studencheskaya St., Voronezh, 394036;
Phone: +7 (473) 259-89-90
References
1. Avdeev S.N., Leshchenko I.V., Aisanov Z.R. et al. New clinical guidelines for COPD – a paradigm shift. Terapevticheskiy Arkhiv, 2024, vol. 96, no. 3, pp. 292-297. (In Russ.)
2. Vasilyeva L.V., Gosteva E.V., Suslova E.Yu., Latysheva M.N., Andreeva V.V., Inshakova K.Yu. Relationship of systemic inflammation with obstructive sleep apnea severity in elderly men with chronic obstructive pulmonary disease. Prakticheskaya Meditsina, 2024, vol. 22, no. 1, pp. 53-57. (In Russ.)
3. Dedov I.I., Shestakova M.V., Melnichenko G.A. et al. Interdisciplinary Clinical Practice Guidelines “Management of Obesity and Its Comorbidities”. Obesity and Metabolism, 2021, vol. 18, no. 1, pp. 5-99. (In Russ.)
4. Drapkina O.M., Budnevskiy A.V., Ovsyannikov E.S., Kontsevaya A.V., Drobysheva E.S. Sarcopenic obesity: patterns and paradoxes. Russian Journal of Preventive Medicine, 2021, vol. 24, no. 1, pp. 73-78. (In Russ.)
5. Sergeeva V.A., Runikhina N.K. Pathogenetic and Clinical Relationships between Chronic Obstructive Pulmonary Disease, Sarcopenia and Frailty. Russian Journal of Geriatric Medicine, 2024, vol. 1, no. 17, pp. 40-48. (In Russ.)
6. Bestall J.C., Paul E.A., Garrod R. et al. Usefulness of the Medical Research Council (MRC) Dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 1999, vol. 54, no. 7, pp. 581-586. https://doi.org/10.1136/thx.54.7.581
7. Choe E.K., Lee Y., Kang H.Y. et al. Association between CT-measured abdominal skeletal muscle mass and pulmonary function. Journal of Clinical Medicine, 2019, vol. 8, no. 5, pp. 667. https://doi.org/10.3390/jcm8050667
8. Cruz-Jentoft A.J., Bahat G., Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 2019, vol. 48, no. 1, pp. 16-31. https://doi.org/10.1093/ageing/afy169
9. de Campos G.C., Lourenço R.A., Lopes C.S. Prevalence of sarcopenic obesity and its association with functionality, lifestyle, biomarkers and morbidities in older adults: the FIBRA-RJ Study of Frailty in Older Brazilian Adults. Clinics (Sao Paulo), 2020, no. 75, pp. e1814. https://doi.org/10.6061/clinics/2020/e1814
10. Donini L.M., Busetto L., Bischoff S.C. et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement. Obesity Facts, 2022, vol. 15, no. 3, pp. 321-335. https://doi.org/10.1159/000521241
11. Gao Q., Mei F., Shang Y. et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin. Nutr., 2021, vol. 40, no. 7, pp. 4633-4641. https://doi.org/10.1016/j.clnu.2021.06.009
12. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024. Available: http://www.goldcopd.org/ Accessed September 27, 2025
13. Gruffydd-Jones K., Marsden H.C., Holmes S. et al. Utility of COPD Assessment Test (CAT) in primary care consultations: a randomised controlled trial. Prim. Care Respir. J., 2013, vol. 22, no. 1, pp. 37-43. https://doi.org/10.4104/pcrj.2013.00001
14. Ida S., Kaneko R., Murata K. SARC-F for screening of sarcopenia among older adults: A meta-analysis of screening test accuracy. Journal of the American Medical Directors Association, 2018, no. 19, pp. 685-689. https://doi.org/10.1016/j.jamda.2018.04.001
15. Koo H.K., Park J.H., Park H.K. et al. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PloS One, 2014, vol. 9, no. 10, pp. e110448. https://doi.org/10.1371/journal.pone.0110448
16. Ohara D.G., Pegorari M.S., Oliveira Dos Santos N.L. et al. Cross-sectional study on the association between pulmonary function and sarcopenia in Brazilian community-dwelling elderly from the Amazon Region. The Journal of Nutrition, Health, Aging, 2020, vol. 24, no. 2, pp. 181-187. https://doi.org/10.1007/s12603-019-1290-y
17. Park C.H., Yi Y., Do J.G. et al. Relationship between skeletal muscle mass and lung function in Korean adults without clinically apparent lung disease. Medicine (Baltimore), 2018, no. 97, pp. e12281. https://doi.org/10.1097/MD.0000000000012281
18. Schrager M.A., Metter E.J., Simonsick E. et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol., 2007, no. 102, pp. 919-925. https://doi.org/10.1152/japplphysiol.00627.2006
19. Sepúlveda-Loyola W., Osadnik C., Phu S. et al. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle, 2020, vol. 11, no. 5, pp. 1164-1176. https://doi.org/10.1002/jcsm.12600
20. van Bakel S.I.J., Gosker H.R., Langen R.C., Schols A.M.W.J. Towards personalized management of sarcopenia in COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 2021, no. 16, pp. 25-40. https://doi.org/10.2147/COPD.S280540
21. Wang Z., Zhou X., Deng M. et al. Clinical impacts of sarcopenic obesity on chronic obstructive pulmonary disease: a cross-sectional study. BMC Pulm. Med., 2023, no. 23, pp. 394. https://doi.org/10.1186/s12890-023-02702-2
22. Zhang Q., Li Y.X., Li X.L. et al. A comparative study of the five-repetition sit-to-stand test and the 30-second sit-to-stand test to assess exercise tolerance in COPD patients. Int. J. Chron. Obstruct. Pulmon. Dis., 2018, no. 13, pp. 2833-2839. https://doi.org/10.2147/COPD.S173509
Review
For citations:
Vasilyeva L.V., Popov S.Yu., Gosteva E.V., Suslova E.Yu. The Impact of Sarcopenic Obesity on the Course of Chronic Obstructive Pulmonary Disease in Elderly Men. Tuberculosis and Lung Diseases. 2026;104(1):44-51. (In Russ.) https://doi.org/10.58838/2075-1230-2026-104-1-44-51
Views:
209
JATS XML
Email this article 